Skip to main content
. 2016 Jun 2;6(6):e010981. doi: 10.1136/bmjopen-2015-010981

FigureĀ 6.

FigureĀ 6

Likelihood of choosing chemotherapy for early-stage breast cancer under different doctor's estimate of risk and GEP test score simulation scenarios in the sample of n=1004 women from the general population. All other attribute levels were held constant (trust in cancer treatment doctor=somewhat trust, and both likelihood of temporary and permanent side effects=moderate). GEP, gene expression profiling; SE, side effects; MD, cancer treatment doctor.